Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 6, 1997, Pages 322-325

  McKay, Judith A ^a   Murray, Graeme I ^b   Keith, W Nicol ^c   McLeod, Howard L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Amplification; Biotinylated tyramide; Fluorescent in situ hybridisation

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; FORMALDEHYDE; ISOPROPAMIDE IODIDE; PARAFFIN; STREPTAVIDIN;

ARTICLE; AUTOFLUORESCENCE; CHROMOSOME ABERRATION; COLON TUMOR; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE FIXATION;

EID: 0031470156     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.6.322     Document Type: Article

References (15)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Yaremko ML, Wasylyshyn ML, Westbrook CA, Michelassi F. Oncogenes, suppressor genes, and allele losses in colon cancer. Adv Surg 1993;26:323-32.
3. Iacopetta B, DiGrandi S, Dix B, Haig C, Soong R, House A. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma. Eur J Cancer 1994;30A:664-70.
4. Jen J, Kim H, Piantadosi S, Liu Z-F, Levitt RC, Sistonen P, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
5. Trask BJ. Fluorescence in situ hybridisation: applications in cytogenetics and gene mapping. Trends Genet 1991;7:149-51.
6. Larsson LI. Immunocytochemistry. Theory and practice. Boca Raton: CRC Press Inc, 1989.
7. Rost FWD. Fluorescence microscopy. In: Pearse AGE, ed Histochemistry theoretical and applied. London: Churchill Livingstone, 1980:346-78.
8. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a novel method of signal amplification. J Immunol Methods 1989;125:279-85.
9. Bobrow MN, Shaughnessy KJ, Litt GJ. Catalyzed reported deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J Immunol Methods 1991;137:103-12.
10. Bobrow MN, Litt GJ, Shaughnessy KJ, Mayer PC, Conlon J. The use of catalyzed reporter deposition as a means of signal amplification in a variety of formats. J Immunol Methods 1992;150:145-9.
11. Berghorn KA, Bonnett JH, Hoffman GE. cFos immunoreactivity is enhanced with biotin amplification. J Histochem Cytochem 1994;42:1635-42.
12. Raap AK, van de Corput MPC, Vervenne RAW, van Gijlswijk RPM, Tanke HJ, Wiegant J. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum Mol Gen 1995;4:529-34.
13. Kerstens HJM, Poddighe PJ, Hanselaar AGJM. A novel in situ hybridisation signal amplification method based on the deposition of biotinylated tyramide. J Histochem Cytochem 1995;43:347-52.
14. Hopman AHN, Poddighe P, Moesker O, Ramaekers FCS. Interphase cytogenetics: an approach to the detection of genetic aberrations in tumours. In: CS Herrington, JO'D McGee, eds. Diagnostic molecular pathology, a practical approach. Oxford: IRL Press, 1992:141-67.
15. Murphy DS, McHardy P, Coutts J, Mallon EA, George WD, Kaye SB, et al. Interphase cytogenetic analysis of erbB2 and topolla co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Int J Cancer 1995;64:18-26.